Verti-GO 16 Tablet
Marketer
Halden Healthcare & Research Pvt Ltd
Salt Composition
Betahistine (16mg)
Overview Verti-GO 16 Tablet
Ménière's disease, an inner ear disorder causing vertigo, tinnitus, and hearing loss (likely due to excess inner ear fluid), is addressed by Verti-GO 16 Tablets. These tablets alleviate symptoms by managing fluid levels. For optimal results, swallow Verti-GO 16 whole with water, consistently at the same time(s) daily, as directed by your physician. Treatment may extend for several months; continue as prescribed, even with symptom improvement. Common side effects include headache, nausea, and dyspepsia; abdominal pain and bloating are also possible. Consuming the medication with food may mitigate gastrointestinal discomfort. Prior to commencing treatment, discuss your medical history, including any stomach ulcers, asthma, or blood pressure irregularities (high or low), and all other medications with your doctor. This is also crucial if you are pregnant, planning pregnancy, or breastfeeding.
Primary Ingredients of Verti-GO 16 Tablet
The provided text is "undefined," which lacks any meaning or content to rephrase. Therefore, no rewritten text can be provided.
Uses of Verti-GO 16 Tablet
Managing Meniere's Disease
Major Benefits of Verti-GO 16 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Verti-GO 16 Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Verti-GO 16 Tablet:
- Headache
- Indigestion
- Nausea
- Stomach pain
- Bloating
How to use Verti-GO 16 Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the Verti-GO 16 Tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, though consistent timing is recommended.
How Verti-GO 16 Tablet works:
Verti-GO 16 Tablets utilize a histamine-like compound to alleviate Ménière's disease symptoms. The medication enhances inner ear circulation, thereby lessening the pressure from fluid buildup. This fluid accumulation triggers nausea, vertigo, and dizziness by sending aberrant signals to the brain. Furthermore, Verti-GO 16 Tablets attenuate these signals, providing Ménière's sufferers with symptomatic relief.
SAFETY ADVICE
AlcoholSAFE
Verti-GO 16 Tablet's interaction with alcohol does not produce adverse reactions.
PregnancyCONSULT YOUR DOCTOR
The use of Verti-GO 16 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against possible risks prior to prescribing. Medical advice is recommended.
Breast feedingCONSULT YOUR DOCTOR
The use of Verti-GO 16 Tablets while breastfeeding is likely inadvisable. Scant human evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Verti-GO 16 Tablet.
KidneySAFE IF PRESCRIBED
The use of Verti-GO 16 Tablet in individuals with kidney disease appears to present a low risk. Current evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Data regarding Verti-GO 16 Tablet use in individuals with hepatic impairment is scarce. Physician consultation is recommended.
What if you forget to take Verti-GO 16 Tablet :
Omit any missed Verti-GO 16 Tablet dose and resume your usual regimen. Avoid taking a double dose.
Facts to Know About Verti-GO 16 Tablet
| Label | Value |
|---|---|
| Chemical Type | Histamine Receptor Agonist |
| Developing Habits | No. |
| Type of Therapy | Neuroscience (CNS) |
| Behavior Class | Meniere's Disease and Histamine Analogs |


